Quarterly report · Q2
2160.TEDINET S100ROIG
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.1bn | 2023-01-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥9.9bn | 2023-04-01 → 2023-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥17.4bn | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥8.2bn | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥4.2bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS |
| Operating income | ¥5.5bn | 2023-01-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥5.1bn | 2023-04-01 → 2023-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥1.0bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥526m | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥5.1bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥5.2bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥768m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥790m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥443m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥1.7bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥1.7bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥389m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥676m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥325m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥4.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥4.4bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss IFRS |
| Net income | −¥868m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥198m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥126m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥45.1bn | at 2023-06-30 | Cons. | Assets IFRS |
| Total assets | ¥33.9bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥35.3bn | at 2022-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥20.3bn | at 2023-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥14.1bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥24.8bn | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.8bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥21.8bn | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.3bn | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥23.0bn | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥21.0bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥22.0bn | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥14.1bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥11.0bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.5bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.4bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥872m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥393m | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥389m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥2.6bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥4.1bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥3.9bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥646m | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥267m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥34.93 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥34.99 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥8.19 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥14.25 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥6.86 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥34.81 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥34.88 | 2023-04-01 → 2023-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥8.11 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥14.18 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥6.83 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 51.0% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 61.8% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 62.5% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 22
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥23m |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥23m |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥512m |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥12.8bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥12.8bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥5.0bn |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥14.1bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥14.1bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥23m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥5.5bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥526m |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥7.0bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥7.0bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥479m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥8.2bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥8.2bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 670
| Item | Context | Value | Unit |
|---|---|---|---|
| Equity IFRS | CurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember | 22976347000 | JPY |
| Equity IFRS | CurrentQuarterInstant_NonControllingInterestsIFRSMember | 1821987000 | JPY |
| Equity IFRS | CurrentQuarterInstant | 24798335000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 790388000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 5117961000 | JPY |
| Depreciation expense ope cf IFRS | Prior1YTDDuration | 239814000 | JPY |
| Depreciation expense ope cf IFRS | CurrentYTDDuration | 274252000 | JPY |
| Decrease increase in trade and other receivables ope cf IFRS | Prior1YTDDuration | -472879000 | JPY |
| Decrease increase in trade and other receivables ope cf IFRS | CurrentYTDDuration | -4060271000 | JPY |
| Increase decrease in trade and other payables ope cf IFRS | Prior1YTDDuration | 161555000 | JPY |
| Increase decrease in trade and other payables ope cf IFRS | CurrentYTDDuration | -332147000 | JPY |
| Decrease increase in inventories ope cf IFRS | Prior1YTDDuration | -150680000 | JPY |
| Decrease increase in inventories ope cf IFRS | CurrentYTDDuration | 109315000 | JPY |
| Bonus allowance ope cf IFRS | Prior1YTDDuration | -21543000 | JPY |
| Bonus allowance ope cf IFRS | CurrentYTDDuration | -26766000 | JPY |
| Finance income and finance costs ope cf IFRS | Prior1YTDDuration | 358503000 | JPY |
| Finance income and finance costs ope cf IFRS | CurrentYTDDuration | 435807000 | JPY |
| Other changes in working capital ope cf IFRS | Prior1YTDDuration | 335458000 | JPY |
| Other changes in working capital ope cf IFRS | CurrentYTDDuration | 228858000 | JPY |
| Subtotal ope cf IFRS | Prior1YTDDuration | 1240618000 | JPY |
| Subtotal ope cf IFRS | CurrentYTDDuration | 1747009000 | JPY |
| Interest received ope cf IFRS | Prior1YTDDuration | 26272000 | JPY |
| Interest received ope cf IFRS | CurrentYTDDuration | 52577000 | JPY |
| Interest paid ope cf IFRS | Prior1YTDDuration | -6492000 | JPY |
| Interest paid ope cf IFRS | CurrentYTDDuration | -10965000 | JPY |
| Income taxes refund paid ope cf IFRS | Prior1YTDDuration | -871133000 | JPY |
| Income taxes refund paid ope cf IFRS | CurrentYTDDuration | -916242000 | JPY |
| Net cash provided by used in operating activities IFRS | Prior1YTDDuration | 389264000 | JPY |
| Net cash provided by used in operating activities IFRS | CurrentYTDDuration | 872378000 | JPY |
| Net decrease increase in time deposits inv cf IFRS | Prior1YTDDuration | -948500000 | JPY |
| Net decrease increase in time deposits inv cf IFRS | CurrentYTDDuration | -1556800000 | JPY |
| Purchase of property plant and equipment inv cf IFRS | Prior1YTDDuration | -202521000 | JPY |
| Purchase of property plant and equipment inv cf IFRS | CurrentYTDDuration | -601480000 | JPY |
| Purchase of intangible assets inv cf IFRS | Prior1YTDDuration | -348338000 | JPY |
| Purchase of intangible assets inv cf IFRS | CurrentYTDDuration | -425754000 | JPY |
| Increase of rent deposit inv cf IFRS | Prior1YTDDuration | -261000 | JPY |
| Increase of rent deposit inv cf IFRS | CurrentYTDDuration | -3625000 | JPY |
| Decrease of rent deposit inv cf IFRS | Prior1YTDDuration | 441000 | JPY |
| Decrease of rent deposit inv cf IFRS | CurrentYTDDuration | － | JPY |
| Collection of loans receivable inv cf IFRS | Prior1YTDDuration | 2371000 | JPY |
| Collection of loans receivable inv cf IFRS | CurrentYTDDuration | 2371000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | -1496808000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | -2585288000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | Prior1YTDDuration | -200000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | CurrentYTDDuration | 800000000 | JPY |
| Capital contribution from non controlling interests fin cf IFRS | Prior1YTDDuration | － | JPY |
| Capital contribution from non controlling interests fin cf IFRS | CurrentYTDDuration | 3239999000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -56269000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -97079000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | Prior1YTDDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |